← Back to Search

Cannabinoid

CBD (Hemp oil) Tincture for Cannabidiol

Phase 1
Waitlist Available
Research Sponsored by Advanced Pain and Rehab Specialists
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Speaks English
Previously have used CBD or marijuana
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This study is evaluating whether cannabidiol (CBD) from hemp oil may help improve pain, anxiety, and sleep quality for individuals with chronic pain, anxiety, and insomnia.

Eligible Conditions
  • Cannabidiol
  • Chronic Pain
  • Anxiety
  • Insomnia
  • Opioid Use Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain score
Secondary outcome measures
Anxiety
Insomnia Score
Narcotic use reduction

Trial Design

2Treatment groups
Active Control
Group I: CBD (Hemp oil) TinctureActive Control1 Intervention
1500mg CBD/30ml (50mg/dose) once daily dosing for total of 4 weeks. Patients will record outcome in pain, anxiety, sleep, and report any adverse effects.
Group II: CBD(hemp oil) creamActive Control1 Intervention
cream 2000mg/1oz (50mg/dose) once daily dosing for a total of 4 weeks to area of most pain.Patients will record outcome in pain, anxiety, sleep, and report any adverse effects.

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Advanced Pain and Rehab SpecialistsLead Sponsor
Hemp synergisticsUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Mar 2025